Inventor

MCKEARN JOHN P

US31 patents

⚠️ This page may combine multiple inventors who share the name “MCKEARN JOHN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MCKEARN JOHN P

SEARLE & CO

Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia

Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides

Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors

Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;s for multi-lineage hematopoietic cell production

Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them

Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia

Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors

Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors

G-CSF receptor agonists

Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods

Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;s or cytokines for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;s for multi-lineage hematopoietic cell production

Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides

Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives

Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives

Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives

Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives

Therapeutic methods using interleukin-3 (IL-3) human/murine hybrid polypeptides

Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same

Method of using phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives

Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives

Thrombopoietin: IL-3 fusion protein

(unassigned)

Methods of using multivariant IL-3 hematopoiesis fusion protein

Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;s for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;S for multi-lineage hematopoietic cell production

PHARMACIA CORP

Fused G-CSF and IL-3 proteins and uses thereof

Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia

PFIZER

Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent

Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production